Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation
暂无分享,去创建一个
Hitoshi Nishizawa | Shiro Fukuda | Yoshimitsu Tanaka | T. Funahashi | I. Shimomura | S. Fukuda | H. Nishizawa | N. Maeda | S. Kita | Iichiro Shimomura | Tadashi Nakamura | Tohru Funahashi | Y. Fujishima | Shunbun Kita | Norikazu Maeda | Tadashi Nakamura | Jun Murai | Akihito Otsuka | Hirofumi Nagao | Yasuna Sakai | Masahide Suzuki | Shinji Yokota | Hidetoshi Tada | Mayumi Doi | Yuya Fujishima | M. Doi | J. Murai | Akihito Otsuka | H. Nagao | Hidetoshi Tada | Yoshimitsu Tanaka | Y. Sakai | Masahide Suzuki | Shinji Yokota | Shunbun Kita | Hirofumi Nagao
[1] T. Funahashi,et al. Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects , 2016, Cardiovascular Diabetology.
[2] T. Funahashi,et al. Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice. , 2015, Endocrinology.
[3] Clifford Goodman,et al. American Academy of Physical Medicine and Rehabilitation , 1988 .
[4] Jose M Garcia,et al. Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review , 2014, Gerontology.
[5] W. Hiatt,et al. Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.
[6] 岡内 幸義. Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men , 2008 .
[7] Hisashi Yamanaka,et al. Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition , 2011, Nucleosides, nucleotides & nucleic acids.
[8] E. Stålberg,et al. Motor nerve conduction studies: measurement principles and interpretation of findings. , 1995, Journal of clinical neurophysiology.
[9] J. Baeyens,et al. Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.
[10] J. Adam,et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. , 2013, Journal of the American Medical Directors Association.
[11] V. Mohan,et al. The prevalence of presarcopenia in Asian Indian individuals with and without type 2 diabetes. , 2013, Diabetes technology & therapeutics.
[12] Weiping Jia,et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.
[13] T. Funahashi,et al. Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes. , 2011, Atherosclerosis.
[14] P Zimmet,et al. Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[15] S. Bandinelli,et al. Dynapenic Abdominal Obesity as a Predictor of Worsening Disability, Hospitalization, and Mortality in Older Adults: Results From the InCHIANTI Study , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] E. Oda. New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[17] T. Yoshimoto,et al. Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? , 2016, Cardiovascular Diabetology.
[18] J. Pell,et al. Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study , 2017, Diabetes Care.
[19] Makoto Nishida,et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. , 2005, Diabetes care.
[20] Taotao Wang,et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly , 2016, Scientific Reports.
[21] Y. Hwang,et al. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype , 2016, Cardiovascular Diabetology.
[22] [Evidence-based practice guideline for the treatment of CKD]. , 2009, Nihon Jinzo Gakkai shi.
[23] Evidence-based Practice Guideline for the Treatment of CKD , 2009, Clinical and Experimental Nephrology.
[24] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[25] Jeffrey R Stout,et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) , 2014, Age and ageing.
[26] E. Kang,et al. Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008–2011) , 2017, Cardiovascular Diabetology.
[27] H. Makizako,et al. Using two different algorithms to determine the prevalence of sarcopenia , 2014, Geriatrics & gerontology international.
[28] L. Ferrucci,et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[29] Kozo Nakamura,et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys , 2016, Osteoporosis International.
[30] Emile R Mohler,et al. Peripheral arterial disease: identification and implications. , 2003, Archives of internal medicine.
[31] J. Després,et al. Effects of Diet and Physical Activity on Adiposity and Body Fat Distribution: Implications for the Prevention of Cardiovascular Disease , 1993, Nutrition Research Reviews.
[32] H. Kaneto,et al. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. , 2009, Atherosclerosis.
[33] P. Scherer,et al. Targeting adipose tissue in the treatment of obesity-associated diabetes , 2016, Nature Reviews Drug Discovery.
[34] A. Newman,et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[35] S. Bandinelli,et al. Sarcopenic obesity and inflammation in the InCHIANTI study. , 2007, Journal of applied physiology.
[36] Eliseo Guallar,et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.
[37] M. Sargin,et al. Relation of Muscle Indices with Metabolic Parameters and C-Peptide in Type 2 Diabetes Mellitus. , 2017, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[38] M. Floeter,et al. Practice parameter: Electrodiagnostic studies in carpal tunnel syndrome: Report of the American Association of Electrodiagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation , 2002, Neurology.
[39] J. Shaw,et al. Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.
[40] T. Yoshimoto,et al. Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes , 2018, Diabetes/metabolism research and reviews.
[41] L. Peng,et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.
[42] E. Stålberg,et al. Association of muscle strength and electrophysiological measures of reinnervation in diabetic neuropathy , 1998, Muscle & nerve.
[43] Khalid Yusoff,et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study , 2015, The Lancet.
[44] M. Malavolti,et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years , 2003, Annals of human biology.
[45] I. Kanazawa,et al. Reduced muscle mass and accumulation of visceral fat are independently associated with increased arterial stiffness in postmenopausal women with type 2 diabetes mellitus. , 2016, Diabetes research and clinical practice.
[46] J. Baeyens,et al. European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .
[47] L. Kuller,et al. Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes , 2009, Diabetes Care.
[48] Ho-Young Son,et al. Epidemic obesity and type 2 diabetes in Asia , 2006, The Lancet.
[49] Eiji Oda,et al. New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[50] T. Funahashi,et al. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. , 2011, Journal of atherosclerosis and thrombosis.
[51] T. Funahashi,et al. Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men. , 2010, Atherosclerosis.
[52] S. Bandinelli,et al. Insulin resistance and muscle strength in older persons. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[53] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[54] A. Newman,et al. Decreased Muscle Strength and Quality in Older Adults With Type 2 Diabetes , 2006, Diabetes.
[55] C. Ogden,et al. Associations of Relative Handgrip Strength and Cardiovascular Disease Biomarkers in U.S. Adults, 2011-2012. , 2016, American journal of preventive medicine.
[56] L. Kuller,et al. Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes , 2007, Diabetes Care.